Open AccessHollow Fiber System Model for Tuberculosis: The European Medicines Agency Experience
Author(s) -
Marco Cavaleri,
Efthymios Manolis
Publication year - 2015
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/civ484
Subject(s) - medicine , agency (philosophy) , tuberculosis , fiber , selection (genetic algorithm) , process management , pharmacology , business , artificial intelligence , pathology , computer science , philosophy , chemistry , organic chemistry , epistemology
The in vitro hollow fiber system model has been qualified by the European Medicines Agency as a methodology for use in support of selection and development of antituberculosis regimens. More data are expected to be generated in the future to further characterize its value.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom